SPY332.59-1.74 -0.52%
DIA272.95-0.95 -0.35%
IXIC10,931.89-176.18 -1.59%

Piper Jaffray Maintains Neutral on Ionis Pharmaceuticals, Lowers Price Target to $70

Piper Jaffray maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Neutral and lowers the price target from $75 to $70.

Benzinga · -

Piper Jaffray maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Neutral and lowers the price target from $75 to $70.